Hospiten News

Check the latest news

Hospiten Rambla University Hospital incorporates the most advanced digital technology platform for mammography

Posted on 14-06-2022

Hospiten Rambla University Hospital has acquired a new Senographe Pristina 3D device for mammography. The instrument is the most innovative currently available on the market for this type of device, which places the hospital at the forefront of mammography services.

The Senographe Pristina is the latest full-field digital mammography platform which incorporates the most advanced technology for the performance of high-quality studies. The equipment includes new features for processing, archiving and transmitting digital images, allowing the radiologist to make a more effective diagnosis of breast pathologies, even in dense breasts.

Hospiten's Diagnostic Imaging specialist, Dr. Jose Francisco Haro states that any breast lesion can be located and studied more accurately thanks to the tomosynthesis technique available with the equipment. “No more radiation is needed than for a conventional mammogram,” he explains.

Dr. Haro goes on to point out the stereotaxic biopsy feature, which facilitates 360-degree access to the breast without limitations. He insists that it is important to improve the mammography experience to be able to adapt in a more sensitive way to all of the patients’ needs.

Senographe Pristina is designed to offer a more comfortable patient experience. For that reason, new features like wheelchair accessibility, a finer grid to filter the radiation produced by X-rays and rounder, more ergonomic edges on the detector to maximize well-being and comfort have been added.

Furthermore, the benefits for the operator are numerous, and include tube park positioning, one-button access to preset rotation and a new, more intuitive user interface design. It also allows motorized movements and facilitates positioning and visualization of the axillary tissue with patient-assisted compression.

The new mammography equipment paves the way for future clinical applications whose aim is an increasingly earlier diagnosis of breast cancer with the minimum radiation dose for patients.